STANDARD BIOTOOLS INC. — Director's Dealing 2015

Feb 23, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2015-02-19

Reporting Person: COLELLA SAMUEL D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-19	Common Stock	M	3200	$16	Acquired	22873	Direct
2015-02-19	Common Stock	M	12000	$14	Acquired	34873	Direct
2015-02-19	Common Stock	M	12000	$13.08	Acquired	46873	Direct
2015-02-19	Common Stock	M	8670	$8.3732	Acquired	55543	Direct
2015-02-19	Common Stock	M	2970	$4.4461	Acquired	58513	Direct
2015-02-19	Common Stock	S	38840	$38.9734	Disposed	19673	Direct
2015-02-20	Common Stock	M	5700	$4.4461	Acquired	25373	Direct
2015-02-20	Common Stock	S	5700	$38.9208	Disposed	19673	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-19	Employee Stock Option (Right to Buy)	$16.0	M	3200	Disposed	2023-06-06	Common Stock (3200.0)	Direct
2015-02-19	Employee Stock Option (Right to Buy)	$14.0	M	12000	Disposed	2022-05-16	Common Stock (12000.0)	Direct
2015-02-19	Employee Stock Option (Right to Buy)	$13.08	M	12000	Disposed	2021-09-07	Common Stock (12000.0)	Direct
2015-02-19	Employee Stock Option (Right to Buy)	$8.3732	M	8670	Disposed	2021-01-06	Common Stock (8670.0)	Direct
2015-02-19	Employee Stock Option (Right to Buy)	$4.4461	M	2970	Disposed	2020-01-28	Common Stock (2970.0)	Direct
2015-02-20	Employee Stock Option (Right to Buy)	$4.4461	M	5700	Disposed	2020-01-28	Common Stock (5700.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5561	Indirect

Footnotes

F1: The shares are held by Colella Family Partners, L.P. ("Colella Partners"). The Reporting Person is the General Partner of Colella Partners. The Reporting Person disclaims beneficial ownership of such shares held by Colella Partners, except to the extent of his proportionate pecuniary interest therein, if any.

F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.30 to $39.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.70 to $39.06, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F4: The shares subject to the Option fully vested on June 6, 2014.

F5: The shares subject to the Option fully vested on May 16, 2013.

F6: The shares subject to the Option fully vested on September 8, 2012.

F7: The shares subject to the Option fully vested on January 28, 2012.

F8: The shares subject to the Option fully vested on January 28, 2011.